Deep Brain Stimulation Device Market | Exclusive Report on the Latest Revenue and Future Scope to 2030

Deep Brain Stimulation Device Market Overview:
Deep brain stimulation system consists of an implantable device that is used to produce electrical signals through electrodes that are inserted in some areas of the brain. The factors which contribute to the market growth are rising cases of neurological diseases resulting in mobility issues, rising research & development studies in treatment of neurological diseases. Also, an increase in the adoption of products with technological progression is going to fuel the growth of this market. There is a significant rise observed in the count of age-related diseases such as Parkinson's disease due to the increasing geriatric population, a shift in the lifestyle, obesity, high blood pressure, etc. More than 50 million people suffer from epilepsy, according to the World Health Organization (WHO) report published on September 2021.

The global deep brain stimulation device market was pegged at ~US$ 1.03 billion in 2021. The market is expected to witness a CAGR of ~9.60% from 2022 to 2030.

Alzheimer's disease is the most common cause of dementia, accounting for 60% - 70% of cases. It is estimated that 35.6 million people have dementia, with 7.7 million new cases diagnosed each year. The increasing solutions for treating these diseases by deep brain stimulation devices will significantly grow this market in the forecast period. According to NCBI, in 2019, DBS (deep brain stimulation devices) have been used on over 160,000 patients worldwide for a variety of neurological and non-neurological conditions, with the number growing each year. Research and development initiatives in the neuroscience are increasing day by day; huge investments are seen in drug development for neurological disorders by many pharmaceutical and biotechnology companies.

To access the Sample PDF of this research study, please request here:
https://growthplusreports.com/inquiry/request-sample/deep-brain-stimulation-device-market/7706

Key players:

• Boston Scientific Corporation
• Abbott Laboratories Inc
• Aleva Neurotherapeutics SA
• Medtronic Plc
• Neuropace Inc
• Livanova Plc
• Nexstim OY
• Beijing PINS Medical Co. Ltd
• Functional Neuromodulation Ltd
• Sapiens Labs Pvt. Ltd
• Among others

Segmentation By Products:

• Single Channel
• Dual Channel

By Application

• Pain Management
• Parkinson's Disease
• Epilepsy
• Essential Tremor
• Obsessive-Compulsive Disorder

Regional Analysis-

1. The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.

2. Major factors contributing to the growth of Deep Brain Stimulation Device market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Deep Brain Stimulation Device, and increasing research activities in the field of Deep Brain Stimulation Device.

3. The emergence of local players and new product launches has also played a critical role in boosting the Deep Brain Stimulation Device market in this region.

Browse the full report now: https://growthplusreports.com/report/deep-brain-stimulation-device-market/7706

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Deep Brain Stimulation Device Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Deep Brain Stimulation Device Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

This release was published on openPR.